undamentalytics Newsletter
Sign in

Pmgc Holdings Inc. revenue

Pmgc Holdings Inc.'s revenue was $590,084 in fiscal 2025, down 65.5% on the year before. Over the last twelve months it was $2.6m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232025Dec 2025LTMJun 2026
Revenue7661,7135902,579
Growth on the year before—+123.5%−65.5%—
Gross profit4471,135185801
Gross margin58.4%66.2%31.4%31.1%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Pmgc Holdings Inc. $2.6m — —
Vistagen Therapeutics, Inc. $2.5m 287.3% —
Korro Bio, Inc. $2.4m -62.1% -53.7%
Collplant Biotechnologies Ltd $2.4m 360.4% —
Upstream Bio, Inc. $3.2m 16.0% —
Xenetic Biosciences, Inc. $3.3m 33.3% 14.7%

Compare with peers

Head to head: ELAB vs VTGNELAB vs KRROCLGN vs ELAB

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Pmgc Holdings Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pmgc Holdings Inc.